Table: Phoenixbio -Q1 group results

PhoenixBio

14/08/2025 07:40

Aug 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            400 mln             449 mln           1.76     
                 (-10.9 pct)         (+2.3 pct)       (+14.1 pct) 
  Operating        23 mln               5 mln           167 mln   
                (+306.4 pct)         (-16.9 pct)                  
  Recurring        20 mln              25 mln           168 mln   
                 (-17.9 pct)         (-47.1 pct)                  
  Net              19 mln              23 mln           161 mln   
                 (-17.1 pct)         (-45.0 pct)                  
  EPS             4.74 yen            5.75 yen         39.87 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T